First-Trimester Urinary Bisphenol A Concentration in Relation to Anogenital Distance, an Androgen-Sensitive Measure of Reproductive Development, in Infant Girls
Overview
Authors
Affiliations
Introduction: Evidence from animal models suggests that prenatal exposure to bisphenol A (BPA), a ubiquitous endocrine-disrupting chemical, is associated with adverse reproductive outcomes in females. Exposure during early gestation, a critical period for reproductive development, is of particular concern. Anogenital distance (AGD) is a sensitive biomarker of the fetal hormonal milieu and a measure of reproductive toxicity in animal models. In some studies, the daughters of BPA-exposed dams have shorter AGD than controls. Here, we investigate this relationship in humans.
Methods: BPA was assayed in first-trimester urine samples from 385 participants who delivered infant girls in a multicenter pregnancy cohort study. After birth, daughters underwent exams that included two measures of AGD (AGD-AC: distance from center of anus to clitoris; AGD-AF: distance from center of anus to fourchette). We fit linear regression models to examine the association between specific gravity-adjusted (SPG-adj) maternal BPA concentrations and infant AGD, adjusting for covariates.
Results: BPA was detectable in 94% of women. In covariate-adjusted models fit on 381 eligible subjects, the natural logarithm of SpG-adj maternal BPA concentration was inversely associated with infant AGD-AC [β=−0.56, 95% confidence interval (CI): −0.97, −0.15]. We observed no association between maternal BPA and infant AGD-AF.
Conclusion: BPA may have toxic effects on the female reproductive system in humans, as it does in animal models. Higher first-trimester BPA exposure was associated with significantly shorter AGD in daughters, suggesting that BPA may alter the hormonal environment of the female fetus. https://doi.org/10.1289/EHP875.
The impact of Bisphenol-A on human reproductive health.
Salami E, Rotimi O Toxicol Rep. 2024; 13:101773.
PMID: 39526236 PMC: 11550589. DOI: 10.1016/j.toxrep.2024.101773.
Endocrine Disruptors in Pregnancy: Effects on Mothers and Fetuses-A Review.
Hajjar R, Hatoum S, Mattar S, Moawad G, Ayoubi J, Feki A J Clin Med. 2024; 13(18).
PMID: 39337036 PMC: 11432155. DOI: 10.3390/jcm13185549.
Bisphenol A-What Do We Know? A Global or Local Approach at the Public Health Risk Level.
Charkiewicz A, Omeljaniuk W, Niklinski J Int J Mol Sci. 2024; 25(11).
PMID: 38892416 PMC: 11172700. DOI: 10.3390/ijms25116229.
Barrett E, Sharghi S, Thurston S, Sobolewski Terry M, Loftus C, Karr C Environ Health Perspect. 2023; 131(11):117001.
PMID: 37966231 PMC: 10648757. DOI: 10.1289/EHP12627.
An Overview of the Health Effects of Bisphenol A from a One Health Perspective.
Molina-Lopez A, Bujalance-Reyes F, Ayala-Soldado N, Mora-Medina R, Lora-Benitez A, Moyano-Salvago R Animals (Basel). 2023; 13(15).
PMID: 37570248 PMC: 10417040. DOI: 10.3390/ani13152439.